Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05223673
Title Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (COLSTAR)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Institut de Recherches Internationales Servier
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
University of Michigan Oncology Clinic | Rogel Cancer Center Ann Arbor Michigan 48109 United States Details
Cleveland Clinic Cleveland Clinic Lerner College of Medicine Cleveland Ohio 44195 United States Details
UZA Edegem Edegem 2650 Belgium Details
UZ Leuven Campus Gasthuisberg Leuven 3000 Belgium Details
CHUUCL Namur site Godinne Yvoir 5530 Belgium Details
Rigshospitalet Copenhagen 2100 Denmark Details
Herning Regional Hospital (Regionhospitalet Godstrup) Herning 7400 Denmark Details
Odense Universitetshospital Odense 5000 Denmark Details
Docrates cancer center Helsinki 00180 Finland Details
TAYS (Tampere University Hospital) Tampere 33520 Finland Details
Magyar Honvédség Egészségügyi Központ Onkológiai Osztály Budapest 1062 Hungary Details
Debreceni Egyetem, Klinikai Központ Onkológiai Klinika Debrecen 4032 Hungary Details
Bács-Kiskun Megyei Kórház a Szegedi Tudományegyetem Általános Orvostudomáyi Kar Oktatókórháza Kecskemét 6000 Hungary Details
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ Onkoterápiás Klinika Szeged 6720 Hungary Details
National Cancer Center Hospital East Chiba 277-8577 Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field